Abstract
Nine of 11 patients with social phobia of both the generalized and performance type responded to treatment with clonazepam in total daily doses ranging from 0.75 to 3 mg. Only 2 of these 9 had comorbid panic disorder; the benefit for social phobic symptoms appears independent of clonazepam's putative efficacy for panic disorder.
MeSH terms
-
Adolescent
-
Adult
-
Anxiety Disorders / drug therapy
-
Anxiety Disorders / epidemiology
-
Clonazepam / administration & dosage
-
Clonazepam / therapeutic use*
-
Comorbidity
-
Drug Administration Schedule
-
Female
-
Humans
-
Male
-
Panic
-
Phobic Disorders / drug therapy*
-
Phobic Disorders / psychology
-
Psychiatric Status Rating Scales